The association between spinal cord trauma-sensitive miRNAs and pain sensitivity, and their regulation by morphine

Eric R Strickland1, Sarah A Woller2, Michelle A Hook2

  • 1Department of Neuroscience & Experimental Therapeutics, College of Medicine, Texas A&M Health Science Center, Bryan, TX 77807-3260, USA.

Insights

Spinal cord injury (SCI) alters microRNAs (miRNAs), and morphine may worsen pain by inducing miR21. Targeting specific miRNAs could improve recovery and reduce SCI-related pain sensitivity.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Spinal cord injury (SCI) frequently leads to increased pain sensitivity.
  • Morphine, used for pain management, can have pro-inflammatory effects that worsen chronic pain.
  • SCI alters microRNA (miRNA) expression both at the injury site and distally.

Purpose of the Study:

  • To investigate how morphine affects the expression of SCI-sensitive miRNAs.
  • To determine if SCI-sensitive miRNA expression predicts nociceptive responses in spinal regions distal to the injury.
  • To identify potential therapeutic targets for SCI-induced pain and functional deficits.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to examine miRNA expression in rat models.
  • Experiments involved sham controls, vehicle treatment, and morphine treatment following contusion injury.
  • Samples were collected at 2 and 15 days post-SCI.

Main Results:

  • Expression of miR1, miR124, and miR129-2 at the injury site predicted distal nociceptive responses.
  • SCI-induced miR21 was further upregulated by morphine administration.
  • Interleukin-6 receptor (IL6R) mRNA, a miRNA target, was induced post-SCI and inversely correlated with locomotor function.

Conclusions:

  • Specific miRNAs (miR1, miR124, miR129-2) may mediate the interaction between SCI and distal sensorimotor circuitry adaptation.
  • Morphine's induction of miR21 represents a novel maladaptive response.
  • miR21 and other SCI-sensitive miRNAs are potential therapeutic targets for improving functional recovery and reducing pain after SCI.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.4K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
2.1K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.1K